S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors

被引:2
作者
Mandarino, Angelo [1 ]
Thiyagarajan, Swetha [1 ]
Martins, Allana C. F. [1 ]
da Silva Gomes, Roberto [1 ]
Vetter, Stefan W. [1 ]
Leclerc, Estelle [1 ]
机构
[1] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA
关键词
S100; protein; HMGB1; pancreatic cancer; GLYCATION END-PRODUCTS; CALCIUM-BINDING PROTEIN; CELL-PROLIFERATION; EXPRESSION; RAGE; PROMOTES; INVASION; RECEPTOR; GROWTH; MIGRATION;
D O I
10.3390/biom13081175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is a multifaceted protein that also actively influences the development and progression of tumors. In this study, we investigate the possible correlations, at the transcript level, between S100s and HMGB1 in pancreatic cancer. For this purpose, we calculated Pearson's correlations between the transcript levels of 13 cancer-related S100 genes and HMGB1 in a cDNA array containing 19 pancreatic cancer tumor samples, and in 8 human pancreatic cancer cell lines. Statistically significant positive correlations were found in 5.5% (5 out of 91) and 37.4% (34 of 91) of the possible S100/S100 or S100/HMGB1 pairs in cells and tumors, respectively. Our data suggest that many S100 proteins crosstalk in pancreatic tumors either with other members of the S100 family, or with HMGB1. These newly observed interdependencies may be used to further the characterization of pancreatic tumors based on S100 and HMGB1 transcription profiles.
引用
收藏
页数:16
相关论文
共 90 条
  • [1] RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses
    Akirav, Eitan M.
    Preston-Hurlburt, Paula
    Garyu, Justin
    Henegariu, Octavian
    Clynes, Raphael
    Schmidt, Marie
    Herold, Kevan C.
    [J]. PLOS ONE, 2012, 7 (04):
  • [2] ZEB1 and IL-6/11-STAT3 signalling cooperate to define invasive potential of pancreatic cancer cells via differential regulation of the expression of S100 proteins
    Al-Ismaeel, Qais
    Neal, Christopher P.
    Al-Mahmoodi, Hanaa
    Almutairi, Zamzam
    Al-Shamarti, Ibtihal
    Straatman, Kees
    Jaunbocus, Nabil
    Irvine, Andrew
    Issa, Eyad
    Moreman, Catherine
    Dennison, Ashley R.
    Sayan, A. Emre
    McDearmid, Jonathan
    Greaves, Peter
    Tulchinsky, Eugene
    Kriajevska, Marina
    [J]. BRITISH JOURNAL OF CANCER, 2019, 121 (01) : 65 - 75
  • [3] Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel
    Ali, Asif
    Brown, Victoria
    Denley, Simon
    Jamieson, Nigel B.
    Morton, Jennifer P.
    Nixon, Colin
    Graham, Janet S.
    Sansom, Owen J.
    Carter, C. Ross
    Mckay, Colin J.
    Duthie, Fraser R.
    Oien, Karin A.
    [J]. BMC CLINICAL PATHOLOGY, 2014, 14
  • [4] Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells
    Ang, Chin Wee
    Nedjadi, Taoufik
    Sheikh, Adnan A.
    Tweedle, Elizabeth M.
    Tonack, Sarah
    Honap, Sailish
    Jenkins, Rosalind E.
    Park, B. Kevin
    Schwarte-Waldhoff, Irmgard
    Khattak, Ilyas
    Azadeh, Bahram
    Dodson, Andrew
    Kalirai, Helen
    Neoptolemos, John P.
    Rooney, Paul S.
    Costello, Eithne
    [J]. CARCINOGENESIS, 2010, 31 (09) : 1541 - 1551
  • [5] S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)
    Arumugam, T
    Simeone, DM
    Schmidt, AM
    Logsdon, CD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) : 5059 - 5065
  • [6] S100P promotes pancreatic cancer growth, survival, and invasion
    Arumugam, T
    Simeone, DM
    Van Golen, K
    Logsdon, CD
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5356 - 5364
  • [7] Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models
    Arumugam, Thiruvengadam
    Ramachandran, Vijaya
    Logsdon, Craig D.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (24) : 1806 - 1818
  • [8] Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy
    Arumugam, Thiruvengadam
    Ramachandran, Vijaya
    Sun, Duoli
    Peng, Zhenghong
    Pal, Ashutosh
    Maxwell, David S.
    Bornmann, William G.
    Logsdon, Craig D.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05) : 654 - 662
  • [9] S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
    Arumugam, Thiruvengadam
    Ramachandran, Vijaya
    Gomez, Sobeyda B.
    Schmidt, Ann M.
    Logsdon, Craig D.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4356 - 4364
  • [10] S100P: a novel therapeutic target for cancer
    Arumugam, Thiruvengadam
    Logsdon, Craig D.
    [J]. AMINO ACIDS, 2011, 41 (04) : 893 - 899